Virbac S.A.
VIRP
Ранг среди акций
#4615
Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent... Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent developer and distributor of a wide array of animal health products and services. The company's global operations extend across France, Europe, Latin America, North America, Asia Pacific, the Middle East, and Africa, catering to both domestic companion animals and commercial livestock. Its extensive portfolio encompasses vaccines, dental hygiene products, reproductive health solutions, dermatological treatments, parasiticides, diagnostic instruments, antibiotics, and aquaculture offerings. Furthermore, Virbac supplies specialized veterinary pharmaceuticals for anesthesia, geriatric care, behavioral management, and injectable micronutrients, alongside pet food and electronic identification systems. These diverse solutions are designed to support veterinarians, agricultural producers, and individual pet owners worldwide.
Цена акции
$389.69
Рыночная капитализация
$3.27B
Изменение (1 день)
0.43%
Изменение (1 год)
-6.13%
Страна
FR
Торговля Virbac S.A. (VIRP)
Категория
Healthcare
Выручка компании Virbac S.A. (VIRP)
Выручка на Jun 2026 TTM: $1.77B
Согласно последним финансовым отчетам Virbac S.A., текущая выручка компании (TTM) составляет $1.77B. В 2024 году компания получила выручку $1.45B больше, чем выручке в 2023 году, которая составила $1.38B. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки Virbac S.A. с 2002 по 2026
Выручка на конец каждого года
| Год | Выручка | Изменить |
|---|---|---|
| 2026 (TTM) | $1.77B | 3.15% |
| 2025 | $1.72B | 18.18% |
| 2024 | $1.45B | 5.49% |
| 2023 | $1.38B | 5.66% |
| 2022 | $1.30B | 7.83% |
| 2021 | $1.21B | 6.34% |
| 2020 | $1.14B | 8.07% |
| 2019 | $1.05B | 5.44% |
| 2018 | $998.54M | -3.45% |
| 2017 | $1.03B | 12.74% |
| 2016 | $917.32M | -0.92% |
| 2015 | $925.80M | -1.03% |
| 2014 | $935.43M | -7.59% |
| 2013 | $1.01B | 10.39% |
| 2012 | $916.98M | 13.69% |
| 2011 | $806.57M | 5.31% |
| 2010 | $765.86M | 14.27% |
| 2009 | $670.22M | 8.47% |
| 2008 | $617.87M | -3.61% |
| 2007 | $641.03M | 21.30% |
| 2006 | $528.47M | 20.10% |
| 2005 | $440.02M | -7.65% |
| 2004 | $476.49M | 6.66% |
| 2003 | $446.73M | 15.70% |
| 2002 | $386.10M | 0.00% |
Выручка аналогичных компаний или конкурентов
| Компания | Выручка | Разница в выручке | Страна |
|---|---|---|---|
| $79.67B | 4,394.46% |
US
|
|
| $99.34B | 5,504.13% |
US
|
|
| $64.39B | 3,532.43% |
US
|
|
| $66.40B | 3,646.05% |
US
|
|
| $77.52B | 4,273.32% |
CH
|
